UNSPSC 51282127: Tazobactam

This classification denotes a penicillin antibiotic, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier SE10G96M8W. The European Medicines Agency schedules Tazobactam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10849MIG. Tazobactam generally arises in the molecular formula C10H12N4O5S.

The term TAZOBACTAM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 3, no. 3, 1989, list 29.) TAZOBACTAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3.

UNSPSC 51282127 Tazobactam, a Commodity code, does not align with the actual procurement activity posted under it in recent state and local solicitations. The code nominally describes a specific pharmaceutical compound (tazobactam, a beta-lactamase inhibitor), but the recent opportunities tagged to it span naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and over-the-counter products. None of these solicitations involves tazobactam procurement, and the code shows limited relevance to actual buying patterns in state and local government markets.

The recent opportunities show substantial activity in pharmaceutical procurement across state health agencies, county health departments, and municipal fire departments. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and OTC products with responses due March 26, 2026, serving state and local facilities across Minnesota and Oregon. Seminole County, Florida sought 1,900 units of naloxone and 800 safe drug deactivation systems through an IFB (response due July 26, 2023), while the City of Tampa's Fire Department Rescue Division issued an IFB for 169 line items of medical and first aid supplies with an estimated contract value of $700,000 and a response deadline of March 13, 2026. The Texas Health and Human Services Commission posted an RFI in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription fulfillment programs. These opportunities span state health commissions, counties, cities, and cooperative purchasing alliances across Florida, Texas, Minnesota, and Oregon, but the code's nominal scope does not meaningfully characterize the work actually being solicited. Business development professionals should verify the correct UNSPSC codes with issuing bodies before pursuing opportunities in pharmaceutical supply and medical emergency products, as this code's taxonomy assignment does not reflect current procurement practice.